Perfecting your protein mass spectrometry

AffiPro Sponsors the Clinical & Translational Omics Symposium 2025

AffiPro is proud to be a sponsor of the Clinical & Translational Omics Symposium, taking place October 30 – November 2, 2025.

The symposium will bring together leading researchers, clinicians, and industry representatives to explore the latest advances in omics technologies and their impact on clinical and translational research.

AffiPro is launching new RNase
T1 Column
for
online
RNA
Digestion

• Imobilized RNAase T1 for online digestion compatible with LCMS in a single workflow
• Proven RNAase T1 specificity with good reproducibility in subsequent LCMS runs
• Rapid analysis and increased throughput with minimal sample consumption

The Institute of Microbiology of the Czech Academy of Sciences is entering AffiPro s.r.o as a minority shareholder and strategic partner. By forming the joint venture with one of the largest institutes of the Czech Academy of Sciences, AffiPro is becoming its official spin-off company, and gains access to shared resources and priority licensing of technologies. Institute of Microbiology now owns 13.75% of the new entity, while 86.25% remains in the possession of the current owners of AffiPro. This join effort aims at Institute of Microbiology plans to commercialize some of its unique technologies while also helps AffiPro to intensify its activities in development of new tools for biotech industry and structural mass spectrometry.
https://lnkd.in/eAq6gMJE